Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy

Transplantation

Volumn 85, Issue 6, 2008, Pages 850-854

  Saad, Ehab R ^a   Bresnahan, Barbara A ^a   Cohen, Eric P ^a   Lu, Na ^a   Orentas, Rimas J ^a   Vasudev, Brahm ^a   Hariharan, Sundaram ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

BK viremia; Immunosuppression reduction; Kidney transplantation

Indexed keywords

BASILIXIMAB; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS DNA;

ACUTE GRAFT REJECTION; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; BK VIRUS; CALCINEURIN INHIBITOR TOXICITY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; NEPHRITIS; PREGNANCY; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIREMIA; VIRUS LOAD;

ACUTE DISEASE; ADULT; AGED; BK VIRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; PREDNISONE; TACROLIMUS; TUMOR VIRUS INFECTIONS;

EID: 41149157586     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318166cba8     Document Type: Article

References (20)

1. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyoma virus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277.
2. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyoma virus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488.
3. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145.
4. Hirsch HH, Steiger J. Polyoma virus BK. Lancet Infect Dis 2003; 3: 611.
5. Kuypers DR, Vandooren AK, Lerut E, et al. Adjuvant low-dose cidofovir therapy for BK polyoma virus interstitial nephritis in renal transplant recipients. Am J Transplant 2005; 5: 1997.
6. Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006; 81: 704.
7. Chandraker A, Ali S, Drachenberg C. Use of fluoroquinolones to treat BK infection in renal transplant recipients. Am J Transplant 2004; 4(suppl 8): 587.
8. Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients. Transplantation 2006; 81: 117.
9. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyoma virus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309.
10. Vasudev B, Hariharan S, Hussain SA, et al. BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68: 1834.
11. Ramos E, Drachenberg CB, Portocarrero M, et al. BK virus nephropathy diagnosis and treatment: Experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002; 143.
12. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582.
13. Buehrig CK, Lager DJ, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665.
14. Hariharan S. BK virus nephritis after renal transplantation. Kidney Int 2006; 69: 655.
15. Celik B, Shapiro R, Vats A, et al. Polyomavirus allograft nephropathy: Sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant 2003; 3: 1378.
16. Hymes LC, GreenBaum L, Amaral SG, et al. Polyomavirus (BK) in pediatric renal transplants: Evaluation of viremic patients with and without BK associated nephritis. Pediatr Transplant 2006; 10: 920.
17. Vandercam B, Moreau M, Goffin E, et al. Cidofovir-induced end-stage renal failure. Clin Infect Dis 1999; 29: 948.
18. Farasati NA, Shapiro R, Vats A, et al. Effect of leflunomide and cidofovir on replication of BK-virus in an in vitro culture system. Transplantation 2005; 79: 116.
19. Williams JW, Javaid B, Kadambi PV, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005; 352: 1157.
20. Moens U, Subramaniam N, Johansen B, et al. A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity. J Virol 1994; 68: 2398.